United in Compassion (UIC) has announced the addition of a regulatory compliance training session to its Australian Medicinal Cannabis Symposium 2025 and pushed the early-bird ticket deadline back to October 15.
The session will be led by legal and regulatory specialists, including Australian Medicinal Cannabis Association (AMCA) chair Dr Teresa Nicoletti and Enimera RegsPlus director and consultant Dr Mary Nteris. It will offer a thorough breakdown of key compliance areas, covering:
- The implications of medicinal cannabis being a registered medicine in Australia.
- How to comply with advertising regulations for scheduled medicines.
- The implications of recent disciplinary action and how to avoid it.
The three-day symposium is scheduled during Medicinal Cannabis Awareness Week 2025 at Brisbane's Royal International Convention Centre from February 21-23. Its central theme is 'Optimising Quality and Compliance', with dedicated program streams for prescribers, nurses, pharmacists and cultivators.
Both the Therapeutic Goods Administration and the Office of Drug Control have confirmed their attendance. A '50 shades of green' themed party is also planned at the Tivoli Theatre on the Saturday evening.
Topics across the three days include:
- Does cannabis cause psychosis?
- Cannabis use in the elderly and why this demographic is growing so quickly.
- Safe prescribing guidelines for high-THC medicine.
- Cannabis use in the veteran and first responder populations.
- Cannabis prescribing for paediatric populations.
- Cannabis use and the opioid crisis. Can it help? How much? How?
For more information and to book, click here.
